AKT1 and mantle cell lymphoma: The addition of CQ increased PI3K/AKT/mTOR inhibitor-induced cell death in models of malignant peripheral nerve sheath tumors and in mantle cell lymphoma cells that were resistant to Akt/mTOR targeting, resulting in induction of cell death via apoptosis [64], [65].